Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Penalized Likelihood Models with Shared Log-Normal Frailty were used to determine the correlation between discharge time and relapse and to identify risk factors. A total of 683 relapses were observed in males, and 422 relapses in females. The Relapse Hazard Ratio (RHR) decreased with age (RHR = 0.99,...
Introduction: Medication discontinuation in remitted single episode patients after a period of...
Background: Currently around 450 million people worldwide suffer from mental disorders. Patients wit...
This journal suppl. entitled: Abstracts for the 12th International Congress on Schizophrenia Researc...
Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outc...
<strong>Objectives</strong>: Schizophrenia patients often experience relapses once and even more wit...
Objectives: Relapse is very much associated with the management of disorder during the treatment, bu...
Background and Objectives: Schizophrenia is one of the most severe psychiatric disorders that has a ...
Objective: Relapses represent one of the main problems of schizophrenia management. This article rev...
Objective: Schizophrenia is to be emphasized due to its high prevalence, severity of symptoms and fr...
eposterWe aim to determine risk and protective factors influencing relapse incidence in outpatient w...
AIM: To assess associations between relapses and psychosocial outcomes in adult patients with schizo...
Objective: Relapse prevention is the main goal of maintenance treatment in schizophrenia. This study...
Background: Clinical decisions about relapse prevention and maintenance therapy following a first/si...
Abstract Background Schizophrenia is a recurrent, debilitating disease that is rarely curable. Rapid...
Schizophrenia is a psychotic disease that requires long-term treatment. The disease has a remission...
Introduction: Medication discontinuation in remitted single episode patients after a period of...
Background: Currently around 450 million people worldwide suffer from mental disorders. Patients wit...
This journal suppl. entitled: Abstracts for the 12th International Congress on Schizophrenia Researc...
Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outc...
<strong>Objectives</strong>: Schizophrenia patients often experience relapses once and even more wit...
Objectives: Relapse is very much associated with the management of disorder during the treatment, bu...
Background and Objectives: Schizophrenia is one of the most severe psychiatric disorders that has a ...
Objective: Relapses represent one of the main problems of schizophrenia management. This article rev...
Objective: Schizophrenia is to be emphasized due to its high prevalence, severity of symptoms and fr...
eposterWe aim to determine risk and protective factors influencing relapse incidence in outpatient w...
AIM: To assess associations between relapses and psychosocial outcomes in adult patients with schizo...
Objective: Relapse prevention is the main goal of maintenance treatment in schizophrenia. This study...
Background: Clinical decisions about relapse prevention and maintenance therapy following a first/si...
Abstract Background Schizophrenia is a recurrent, debilitating disease that is rarely curable. Rapid...
Schizophrenia is a psychotic disease that requires long-term treatment. The disease has a remission...
Introduction: Medication discontinuation in remitted single episode patients after a period of...
Background: Currently around 450 million people worldwide suffer from mental disorders. Patients wit...
This journal suppl. entitled: Abstracts for the 12th International Congress on Schizophrenia Researc...